Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Intranasal insulin to reduce delirium after heart surgery with a heart-lung machine

Official title: Mechanisms and Intervention Strategies of Perioperative Glycemic Variability on Postoperative Delirium After Cardiac Surgery

Run by Fujian Medical University Union Hospital · NCT07893353 · Data updated 2026-11-12

This study tests whether giving intranasal insulin can reduce glycemic swings and delirium after elective heart surgery with cardiopulmonary bypass.

More Postoperative Delirium trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment225 (estimated)
SponsorFujian Medical University Union Hospital
Academic / other
Locations1 site (Fuzhou, Fujian)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedDecember 31, 2026
Study endsOctober 31, 2028
Registry record updatedOctober 23, 2026
Trial IDNCT07893353 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older scheduled for elective cardiac surgery with CPB who do not have significant psychiatric or neurological disease and do not have severe diabetes.

Probably not a fit

Patients with nasal abnormalities, nasal surgery history, or other exclusion conditions may not benefit and could be excluded from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study focuses on adults undergoing elective cardiac surgery with cardiopulmonary bypass. Researchers will compare intranasal insulin at two dose levels to saline in terms of effects on blood sugar variability, insulin resistance, and the occurrence of postoperative delirium. The goal is to determine if brain-targeted insulin delivery can influence metabolic responses and improve postoperative cognitive outcomes. The study will monitor patients for delirium and collect data on glycemic fluctuations and insulin sensitivity during the perioperative period.

Why it matters

Potential benefit: If successful, intranasal insulin could help reduce delirium risk and support faster recovery after heart surgery.

How similar studies have gone: Previous work has explored metabolic factors and brain-delivery insulin strategies, but this exact approach in post-cardiac delirium remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Scheduled for elective cardiac surgery with CPB

Exclusion Criteria:

* History of psychiatric disorders, neurological diseases, or mild cognitive impairment (MCI) (Mini-Cog score \< 3)
* Severe diabetes mellitus
* Participation in other interventional studies
* Coexistence of severe organic diseases
* Nasal deformities, nasal diseases, or history of nasal surgery

Where it's running

  • Fujian Medical University Union Hospital
    Fuzhou, Fujian, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.